Results 201 to 208 of about 44,917 (208)

Irinotecan and its active metabolite, SN‐38: review of bioanalytical methods and recent update from clinical pharmacology perspectives

Biomedical Chromatography, 2010
Nuggehally Srinivas
exaly  

Clinical and pharmacogenetic factors associated with irinotecan toxicity

Cancer Treatment Reviews, 2008
Hans Gelderblom
exaly  

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial

Cancer Chemotherapy and Pharmacology, 2010
Craig Underhill, Peter Gibbs, Tebbutt Niall C   +2 more
exaly  

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Annals of Oncology, 2009
G Lledo, M Mabro, A Figer
exaly  

Clinical Pharmacokinetics of Irinotecan

Clinical Pharmacokinetics, 2012
G G Chabot
exaly  

Irinotecan

Reactions Weekly, 2008
openaire   +1 more source

Irinotecan

2007
openaire   +1 more source

Irinotecan

Reactions Weekly, 1996
openaire   +1 more source